Enwei Medicine (301331.SZ) announced that as of June 6, 2024, the company has repurchased a total of 2.0918 million shares through a special securities account for repurchase through the centralized bidding trading method, accounting for 2.03% of the total share capital of the company (calculated based on the total share capital of the company as of June 5, 2024). The highest fill price was 44.78 yuan/share, the lowest fill price was 26.79 yuan/share, and the total transaction amount was 75.8162 million yuan (excluding transaction fees).
恩威医药(301331.SZ)已耗资7581.62万元回购2.03%股份
Enwei Medicine (301331.SZ) has spent 75.8162 million yuan to repurchase 2.03% of its shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.